Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective. - Wikidata - wikimedia - TriplyDB

Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.

Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.

http://www.wikidata.org/entity/Q31046062

about

Sudden death: Neurogenic causes, prediction and prevention.Device Management in Heart Failure.[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

P2860

Q47123564-D610D9E1-C689-4559-89EA-B499DC8C6EBA Q47632456-33BBD83B-0B1E-4947-A187-749B34AF93D7 Q52822562-FCEEB723-34C6-4B33-8F00-D70AF3B972BA

P2860

Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.

http://www.wikidata.org/entity/Q31046062

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@ast

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@en

type

label

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@ast

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@en

prefLabel

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@ast

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@en

P1433

Q31046062-4CFE5D45-09A8-4F0A-A0C0-CA7D0541604D

P1476

Q31046062-C1669D23-E98E-4C44-9E36-7801814DA767

P2093

Q31046062-5474C334-A9BD-4C31-A2F9-EFB5EE4BE936

Q31046062-6531CCE3-02B6-42B0-8BEE-B99645DFD6CA

Q31046062-8497D6CC-4122-4589-864F-ED8E53F916BF

Q31046062-C5DF409F-62C7-46F8-BAD3-8CDD55F647B7

Q31046062-F4409A0E-F67A-415F-9C76-780F25ADFE5B

P2860

Q31046062-048C7CA1-8A6B-4C7B-B5C6-3E7A9EC9BBAE

Q31046062-067FBCE5-21E9-4012-B520-7733D8B20C4A

Q31046062-0B2EC8EA-3ED3-4CC2-B888-A28CEF5EB6A4

Q31046062-11C681EF-9D0B-4107-824B-E2569B17865B

Q31046062-2F49C8EE-61C7-4CB4-BFC5-9ACEB6D105C0

Q31046062-3130E5B9-6130-44FA-9879-D53D2F10802A

Q31046062-56EF78A8-73BC-40C1-9610-F6E90BC758FA

Q31046062-5F4BC573-EFE0-4E4D-9B86-A0A7CE9AEC56

Q31046062-612CE9D2-6C57-4A63-AAFC-0DD79B752EB3

Q31046062-6B8972D2-2698-448E-B235-86636BE4536C

P2888

Q31046062-6BEE974D-FA4B-4A0C-A580-65C57F607EAC

P304

Q31046062-1999F462-5EC8-484C-9509-D7BF4624DB8F

P31

Q31046062-AECBD7DA-42E5-4CC4-BE18-666D0A89C3EE

P356

Q31046062-86DF5C06-9F82-41AB-B132-A4976B46517D

P433

Q31046062-DBB5C66D-79A4-48E5-9C88-62A065FD74FF

P478

Q31046062-04D49299-7BC4-45DB-AB4A-A8184E408C73

P577

Q31046062-2525E176-C6EC-4B48-84BD-1538D031B9EE

P6179

Q31046062-0A9D2E3A-3B9D-4C77-819C-C74F2C347419

P698

Q31046062-49B1D4C6-044C-49B6-94AE-D017286C526F

P356

S11897-016-0286-8

P1433

Current heart failure reports

P1476

Baroreflex Activation Therapy ...... e Data and Future Perspective.

@en

P2093

Hannes Reuter

http://www.w3.org/2001/XMLSchema#string

Marcel Halbach

http://www.w3.org/2001/XMLSchema#string

Navid Madershahian

http://www.w3.org/2001/XMLSchema#string

Roman Pfister

http://www.w3.org/2001/XMLSchema#string

Thorsten Fritz

http://www.w3.org/2001/XMLSchema#string

P2860

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.

Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Baroreflex activation for the treatment of heart failure.

Carotid baroreflex activation therapy for resistant hypertension.

Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.

Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves.

P2888

s11897-016-0286-8

P304

71-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-016-0286-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047961658

http://www.w3.org/2001/XMLSchema#string

P698

26879389

http://www.w3.org/2001/XMLSchema#string